Veracyte Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	517.15	445.76	361.05	296.54	219.51
Revenue Growth (YoY)	16.01%	23.46%	21.76%	35.09%	86.85%
Cost of Revenue	154.61	147.62	131.37	120.86	74.4
Gross Profit	362.53	298.15	229.68	175.68	145.11
Selling, General & Admin	210.95	206.04	187.72	170.76	181.19
Depreciation & Amortization Expenses	2.49	3.3	2.11	2.08	15.98
Research & Development	70.81	69.29	57.31	40.6	29.84
Other Operating Expenses	20.51	3.37	68.35	3.32	-
Total Operating Expenses	304.76	282	315.48	216.76	227.02
Operating Income	57.78	16.14	-85.8	-41.08	-81.9
Total Non-Operating Income (Expense)	10.42	9.6	9.18	4.65	0.25
Pretax Income	68.2	25.74	-76.61	-36.43	-81.65
Provision for Income Taxes	1.85	1.61	-2.21	0.13	-6.09
Net Income	66.35	24.14	-74.4	-36.56	-75.56
Net Income to Common	66.35	24.14	-74.4	-36.56	-75.56
Net Income Growth	174.89%	-	-	-	-
Shares Outstanding (Basic)	79	76	73	72	68
Shares Outstanding (Diluted)	81	78	73	72	68
Shares Change (YoY)	3.08%	7.60%	1.53%	5.39%	27.52%
EPS (Basic)	0.84	0.32	-1.02	-0.51	-1.11
EPS (Diluted)	0.82	0.31	-1.02	-0.51	-1.11
EPS Growth	164.52%	-	-	-	-
Free Cash Flow	126.63	63.81	34.26	-1.01	-37
Free Cash Flow Growth	98.45%	86.24%	-	-	-
Free Cash Flow Per Share	1.57	0.82	0.47	-0.01	-0.54
Gross Margin	70.10%	66.88%	63.62%	59.24%	66.11%
Operating Margin	11.17%	3.62%	-23.76%	-13.85%	-37.31%
Profit Margin	12.83%	5.41%	-20.61%	-12.33%	-34.42%
FCF Margin	24.49%	14.31%	9.49%	-0.34%	-16.85%
EBITDA	79.19	39.6	-58.61	-15.15	-62.31
EBITDA Margin	15.31%	8.88%	-16.23%	-5.11%	-28.39%
EBIT	57.78	16.14	-85.8	-41.08	-81.9
EBIT Margin	11.17%	3.62%	-23.76%	-13.85%	-37.31%
Effective Tax Rate	2.71%	6.24%	2.88%	-0.37%	7.45%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q